High-Quality Weight Loss in Obesity: Importance of Skeletal Muscle
Diabetes · 2025
DOI: 10.2337/dbi25-0003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, 2025. Verfasst von Mary-Ellen Harper und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: Obesity, Weight Loss, Muscle, Skeletal. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Institute of Nutrition, Metabolism and Diabetes.
Abstract (Originalsprache)
Treatment responses to behavioral, surgical, and pharmacological approaches in obesity are highly variable in quantity and quality. Here we refer to high-quality weight loss as a high proportion of fat to skeletal muscle mass lost. Given the role of skeletal muscle in energy expenditure, glucose homeostasis, metabolic flexibility, mobility, and strength, excessive loss of skeletal muscle during weight loss is a concern for overall health. Challenges in accurately measuring body composition, especially skeletal muscle, limit our understanding of muscle loss during obesity treatment. Recent incretin-related pharmacotherapies improve muscle metabolic health by enhancing glucose uptake and reducing muscle lipids but, like other weight loss interventions, are associated with muscle loss. Newer pharmacological interventions are being developed to minimize muscle loss, but many questions remain. This article examines the metabolic importance of skeletal muscle and its measurement clinically, as well as key genetic and metabolic factors influencing skeletal muscle and the quality of weight loss. Genetics can affect muscle composition (e.g., fiber types) and function. Together with metabolic factors, including neurohormonal responses and skeletal muscle metabolic efficiency and adaptation, there is variability in weight loss outcomes. In future research investigators should continue to focus on factors affecting skeletal muscle and on personalized strategies to optimize weight loss quality preserving the physical and metabolic functions of skeletal muscle. Article Highlights High-quality weight loss, i.e., a high proportion of fat to skeletal muscle lost during the treatment of obesity, is advantageous for metabolic and physical health. Precise and accurate determinations of skeletal muscle mass in clinical settings are often challenging. In prevention of excessive loss of skeletal muscle during weight loss, advantages include minimization of metabolic adaptation that makes it difficult to sustain weight loss, improved glucose homeostasis and metabolic flexibility, and better mobility and strength. Effective approaches to preserving skeletal muscle include sufficient dietary protein and inclusion of exercise (especially resistance exercise) during weight loss; new pharmacological approaches are under development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Ontario, Canada.
- Division of Endocrinology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
- Division of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
ORCID-Profile: Mary-Ellen Harper, Ruth McPherson
Förderung
- Institute of Nutrition, Metabolism and Diabetes
Zitieren
APA
Harper, M. E., Dent, R. R. M., & McPherson, R. (2025). High-Quality Weight Loss in Obesity: Importance of Skeletal Muscle. Diabetes. https://doi.org/10.2337/dbi25-0003
Vancouver
Harper ME, Dent RRM, McPherson R. High-Quality Weight Loss in Obesity: Importance of Skeletal Muscle. Diabetes. 2025. doi:10.2337/dbi25-0003
BibTeX
@article{Harper2025,
author = {Harper, Mary-Ellen and Dent, Robert R M and McPherson, Ruth},
title = {High-Quality Weight Loss in Obesity: Importance of Skeletal Muscle},
journal = {Diabetes},
year = {2025},
doi = {10.2337/dbi25-0003}
}
EUVIMED